Optimizing the efficacy of exposure in PTSD treatment

European Journal of Psychotraumatology

Volumn 6, Issue , 2015, Pages

  Hendriks, Gert Jan ^a,b   De Kleine, Rianne ^a,b   Minnen, Agnes Van ^a,b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b Pro Persona Centre for Integrative Mental Health Care   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84977104113     PISSN: None     EISSN: 20008066     Source Type: Journal    
DOI: 10.3402/ejpt.v6.27628     Document Type: Article

References (20)

1. Bontempo, A., Panza, K. E., & Bloch, M. H. (2012). D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: A meta-analysis. The Journal of Clinical Psychiatry, 73(4), 533-537. doi: 10.4088/JCP.11r07356.
2. Debiec, J., & Ledoux, J. E. (2004). Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala. Neuroscience, 129(2), 267-272. doi: 10.1016/j.neuroscience.2004.08.018.
3. De Kleine, R. A., Hendriks, G. J., Kusters, W. J., Broekman, T. G., & Van Minnen, A. (2012). A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biological Psychiatry, 71(11), 962-968. doi: 10.1016/j.biopsych.2012.02.033.
4. De Kleine, R. A., Hendriks, G. J., Smits, J. A., Broekman, T. G, & Van Minnen, A. (2014). Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder. Journal of Psychiatric Research, 48(1), 40-46. doi: 10.1016/j.jpsychires.2013.10.008.
5. De Kleine, R. A., Rothbaum, B. O., & Van Minnen, A. (2013). Pharmacological enhancement of exposure-based treatment in PTSD: A qualitative review. European Journal of Psychotraumatology, 4, 21626, doi: 10.3402/ejpt.v4i0.21626
6. Difede, J., Cukor, J., Wyka, K., Olden, M., Hoffman, H., Lee, F. S., et al. (2014). D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: A pilot randomized clinical trial. Neuropsychopharmacology, 39(5), 1052-1058. doi: 10.1038/npp.2013.317.
7. Ipser, J., Seedat, S., & Stein, D. J. (2006). Pharmacotherapy for post-traumatic stress disorder—A systematic review and metaanalysis. South African Medical Journal, 96(10), 1088-1096.
8. Kehle-Forbes, S. M., Polusny, M. A., MacDonald, R., Murdoch, M., Meis, L., & Wilt, T. J. (2012). A systematic review of the efficacy of adding non exposure components to exposure therapy for posttraumatic stress disorder. Psychological Trauma: Theory, Research, Practice and Policy, 5(4), 317-322.
9. Kindt, M., & Soeter, M. (2013). Reconsolidation in a human fear conditioning study: A test of extinction as updating mechanism. Biological Psychology, 92(1), 43-50.
10. Litz, B. T., Salters-Pedneault, K., Steenkamp, M. M., Hermos, J. A., Bryant, R. A., Otto, M. W., et al. (2012). A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. Journal of Psychiatric Research, 46(9), 1184-1190. doi: 10.1016/j.jpsychires.2012.05.006.
11. Marshall, R. D., Lewis-Fernandez, R., Blanco, C, Simpson, H. B., Lin, S. H., Vermes, D., et al. (2007). A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depression and Anxiety, 24(2), 77-84. doi: 10.1002/da.20176.
12. Norberg, M. M., Krystal, J. H., & Tolin, D. F (2008). A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry, 63(12), 1118-1126. doi: 10.1016/j.biopsych.2008.01.012.
13. Olff, M., Van Zuiden, M., Koch, S., Nawijn, L., Frijling, J., & Veltman, D. (2015). Intranasal oxytocin: Miracle cure after trauma? European Journal of Psychotraumatology, 5, 27631, doi: 10.3402/ejpt.v5i0.27631
14. Powers, M. B., Halpern, J. M., Ferenschak, M. P., Gillihan, S. J., & Foa, E. B. (2010). A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clinical Psychology Review, 30(6), 635-641. doi: 10.1016/j.cpr.2010.04.007.
15. Rothbaum, B. O., Cahill, S. P., Foa, E. B., Davidson, J. R., Compton, J., Connor, K M., et al. (2006). Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. Journal of Traumatic Stress, 19(5), 625-638. doi: 10.1002/jts.20170.
16. Rothbaum, B. O., Price, M., Jovanovic, T., Norrholm, S. D., Gerardi, M., Dunlop, B., et al. (2014). A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan war veterans. The American Journal of Psychiatry, 171(6), 640-648. doi: 10.1176/appi.ajp.2014.13121625.
17. Schnurr, P. P., Chard, K M., Ruzek, J. I., Chow, B. K., Shih, M. C, Resick, P. A., et al. (2014). Design of VA Cooperative Study #591: CERV-PTSD, comparative effectiveness research in veterans with PTSD. Contemporary Clinical Trials, 41C, 75-84. doi: 10.1016/j.cct.2014.11.017.
18. Schnurr, P. P., Friedman, M. J., Engel, C. C, Foa, E. B., Shea, M. T., Chow, B. K., et al. (2007). Cognitive behavioral therapy for posttraumatic stress disorder in women: A randomized controlled trial. JAMA, 297(8), 820-830. doi: 10.1001/jama.297.8.820.
19. Simon, N. M., Connor, K. M., Lang, A. J., Rauch, S., Krulewicz, S., LeBeau, R. T., et al. (2008). Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. The Journal of Clinical Psychiatry, 69(3), 400-405.
20. Watts, B. V, Schnurr, P. P., Mayo, L., Young-Xu, Y., Weeks, W B., & Friedman, M. J. (2013). Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. The Journal of Clinical Psychiatry, 74(6), e541-550. doi: 10.4088/JCP.12r08225.